EW
Edwards Lifesciences Corporation
NYQ
$87.66
-0.50
(-0.57%)
Extended · +1.39σ
Grade C
132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$50.5B
P/E ttm
47.4
Fwd P/E
26.0
Beta
0.87
Day range
$87.66
52w range
$74.66 – $89.14
Avg vol
5.1M
RSI(2)
62.9
ROE
10.5%
Net mgn
17.4%
FCF mgn
14.3%
Debt/Eq
0.07
Div yld
—
Sector
Healthcare
Industry
Medical Devices
Next earn
2026-07-23
Matrix setup grades
Long
—
score 18 · tech 18 / 80 · support 0 / 20
above KC1 lower, +1.36 ATR from EMA21 · doji
- · Doji — indecision, watch for reversal
- · Chop regime — mean-reversion favored both ways
Short
C
score 32 · tech 32 / 80 · support 0 / 20
KC1 upper, +1.36 ATR from EMA21 · doji
- · KC1 upper stretch — light pop
- · Doji — indecision, watch for reversal
- · RSI hook from overbought (64)
Options · swing
See more →
CALL
$90
2026-07-17
$2.80
PUT
$90
2026-07-17
$5.00
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-04-23
- EPS (act / est)
- 0.78 / 0.73
- Surprise
- +7.3%
- Next report
- 2026-07-23
About
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replac…